Smarter blood clot care with phone/tablet help
Part of Heart & circulation clinical trials.
This study tests if using a smartphone app or tablet helps doctors and patients work together to prevent or manage blood clots in the legs or lungs. It is for adults in the hospital who have or are at high risk of a blood clot.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must be in the hospital.
- You must currently have or have had a blood clot in a leg or lung, or be at high risk of getting one.
- You must be able to use a smartphone or tablet.
- You must sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses smart technology to help manage the risk of blood clots (called VTE) after you leave the hospital. It focuses on giving you tools to stay safe and healthy during your recovery.
This trial tests whether using smart technology, like apps or devices, can improve care for people with pulmonary thromboembolism (blood clots in the lungs). It aims to help patients manage their condition better and recover more smoothly.
This study looks at a prevention plan to reduce the risk of hospital-acquired blood clots. It may help people who are expected to stay in the hospital for several days but do not already have a clot.
This trial tests a computerized tool that helps doctors decide who needs prevention medicines to lower the risk of blood clots after a hospital stay. It may help reduce preventable clotting risk for people who are less mobile and have added risk factors.
This trial tests a new computer tool that helps doctors decide whether you likely have a blood clot in your leg or lung. If you have symptoms and are not already on blood thinners, you may be able to join.
This study compares a clot-removal device (ClotTriever) plus standard care versus standard blood thinners alone for a deep vein clot in the leg. It aims to see which approach better improves leg symptoms and outcomes.
Hear when a new Venous Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.